Skip to main content
American Journal of Physiology - Endocrinology and Metabolism logoLink to American Journal of Physiology - Endocrinology and Metabolism
. 2013 Jan 15;304(6):E614–E622. doi: 10.1152/ajpendo.00424.2012

Differential responses of pancreatic β-cells to ROS and RNS

Gordon P Meares 1, Dominique Fontanilla 3, Katarzyna A Broniowska 3, Teresa Andreone 4, Jack R Lancaster Jr 2, John A Corbett 3,
PMCID: PMC3602694  PMID: 23321474

Abstract

Reactive oxygen species (ROS) and reactive nitrogen species (RNS) direct the activation of distinct signaling pathways that determine cell fate. In this study, the pathways activated and the mechanisms by which ROS and RNS control the viability of pancreatic β-cells were examined. Although both nitric oxide and hydrogen peroxide (H2O2) induce DNA damage, reduce cell viability, and activate AMPK, the mechanisms of AMPK activation and cell death induction differ between each reactive species. Nitric oxide activates the unfolded protein and heat shock responses and MAPK kinase signaling, whereas H2O2 stimulates p53 stabilization and poly(ADP-ribose) polymerase (PARP) activation but fails to induce the unfolded protein or heat shock responses or MAPK activation. The control of cell fate decisions is selective for the form of stress. H2O2-mediated reduction in β-cell viability is controlled by PARP, whereas cell death in response to nitric oxide is PARP independent but associated with the nuclear localization of GAPDH. These findings show that both ROS and RNS activate AMPK, induce DNA damage, and reduce cell viability; however, the pathways controlling the responses of β-cells are selective for the type of reactive species.

Keywords: reactive oxygen species, reactive nitrogen species, diabetes, endoplasmic reticulum stress, DNA damage, nitric oxide, AMP-activated protein kinase, poly(ADP-ribose) polymerase


reactive oxygen species (ROS) such as hydrogen peroxide (H2O2) and reactive nitrogen species (RNS) such as nitric oxide participate in the regulation of a number of fundamental cellular processes under physiological conditions, including insulin secretion and insulin action (22, 62). ROS function as signaling intermediates in response to cytokines and growth factors and, when produced during the oxidative burst, are essential for proper immune function (62). There is also a role for RNS in controlling signaling cascades that participate in the regulation of diverse biological functions, including vascular relaxation, neurotransmission, and innate immunity (6). In contrast to the physiological roles of these oxidants, enhanced production of ROS and RNS can contribute to disease development.

Previous studies have identified roles for ROS and RNS as mediators of β-cell damage during the onset of insulin-dependent diabetes mellitus (28). Resident intraislet macrophages and invading autoreactive immune cells release proinflammatory cytokines in and around pancreatic islets of Langerhans (35, 42). These proinflammatory cytokines, such as interleukin-1β (IL-1β), stimulate β-cell expression of inducible nitric oxide synthase (iNOS), leading to the generation of nitric oxide (14, 18). Produced in micromolar concentrations by β-cells, nitric oxide inhibits mitochondrial oxidation of glucose to CO2 and glucose-stimulated insulin secretion (12, 14, 16, 17, 31). Following prolonged exposures, cytokines cause β-cell death (12, 14, 16, 17, 31). When supplied exogenously using donor compounds, nitric oxide induces biological responses that are similar to those observed following the induction of iNOS in cytokine-treated β-cells (28, 43, 44, 59). β-Cells are reported to be highly sensitive to free radical-induced damage and cell death because of low levels of free radical defense enzymes such as catalase, superoxide dismutases, and glutathione peroxidase (38). As such, endogenously produced or exogenously supplied nitric oxide results in the inactivation of metabolic enzymes, the inhibition of insulin secretion, and β-cell death (12, 14, 16, 17, 31).

Mammalian cells have the capacity to respond quickly and specifically to damage from environmental and endogenous stress. Two classic examples of stress-specific signaling are the unfolded protein response (UPR) and the DNA damage response (DDR). When misfolded proteins accumulate in the endoplasmic reticulum (ER), the UPR is activated and sends signals from the ER via eukaryotic translation initiation factor 2α kinase 3 (PERK), inositol-requiring enzyme-1 (IRE1), and activating transcription factor 6 that are designed to attenuate protein synthesis and enhance the expression of repair enzymes as a means of adaptation. If the cell is unable to repair the damage, this same pathway may initiate apoptosis (54). The DDR is activated following extensive DNA damage and, like the UPR, functions to limit additional damage by signaling for cell cycle arrest. In addition, the activated DDR signals for repair of DNA damage through the expression and activation of specialized repair enzymes such as poly(ADP-ribose) (PAR) polymerase (PARP) and ataxia telangiectasia mutated (ATM). When necessary, the DDR signals for elimination of the irreparably damaged cell. In many cases, the DNA damage-induced cell death is controlled by the tumor suppressor and transcription factor p53 (10).

Although free radicals are damaging to β-cells, we have shown that β-cells maintain the ability to survive from and repair nitric oxide- and cytokine-induced damage (13, 15, 58, 59). Although these survival mechanisms are just beginning to be elucidated, they include the activation of JNK and the forkhead transcription factor FoxO1 and the enhanced expression of protective enzymes such as GADD45α, PGC-1α, and heat shock proteins (HSP) (30, 44). Additionally, we have shown that AMP-activated protein kinase (AMPK) plays a central role in enhancing metabolic recovery from cytokine-mediated damage and in attenuating β-cell death following nitric oxide-induced damage (30). AMPK is a conserved heterotrimeric serine/threonine kinase that modifies anabolic and catabolic processes through the phosphorylation of multiple substrates in an effort to restore and maintain cellular energy balance (27). The signaling pathways leading to AMPK activation in response to ROS/RNS are not fully understood. We have shown that the upstream kinase LKB1 is dispensable during the activation of AMPK by nitric oxide. The activation of AMPK by nitric oxide is associated with induction of the unfolded protein response and requires the RNase activity of IRE1 (45). In response to ROS, activation of the NAD+-dependent enzyme PARP causes the depletion of cellular energy and the activation of AMPK (29, 53). DNA damage induced by ROS treatment results in the overactivation of PARP, leading to an energy-consuming cycle of ADP-ribosylation of proteins (including PARP itself), followed by the ATP-dependent hydrolysis of this modification (53, 55). The net result is ATP and NAD+ depletion and cell death by programmed necrosis (25). Additionally, PARP activation in response to H2O2 can lead to LKB1-mediated AMPK activation and promotion of autophagy (29, 53).

Although ROS and RNS modify the function and survival of β-cells (21), the intracellular signaling pathways involved in controlling the cellular responses to each oxidant have yet to be fully elucidated. In this study, the mechanistic differences between the stress-induced signaling pathways activated by RNS and ROS in pancreatic β-cells have been examined. We show that ROS and RNS activate distinct cellular stress responses. H2O2 induces a p53- and PARP-dependent DDR. In response to nitric oxide, p53 and PARP are not activated in β-cells. In contrast, nitric oxide activates the unfolded protein and heat shock responses in β-cells. Although both oxidants activate AMPK, it is by different mechanisms. These findings show that selective pathways are activated in β-cells in response to ROS and RNS and that the cellular response, be it protective or damaging, is dependent on the source and length of exposure to ROS/RNS.

MATERIALS AND METHODS

Materials and animals.

Male Sprague-Dawley rats (250–300 g) were purchased from Harlan (Indianapolis, IN). The Institutional Animal Care and Use Committees at The Medical College of Wisconsin and University of Alabama at Birmingham approved all animal care and experimental procedures. INS832/13 cells were provided by Chris Newgard (Duke University, Durham, NC). RPMI 1640, CMRL-1066 tissue culture medium, l-glutamine, streptomycin, and penicillin were purchased from Mediatech (Manassas, VA). Fetal calf serum was purchased from Sigma. Human recombinant IL-1 was purchased from PeproTech (Rocky Hill, NJ). (Z)-1(N,N-diethylamino) diazen-1-ium-1,2-diolate (DEANO) and NOC-15, (Z)-1-[N-(3-ammoniopropyl)-N-(n-propyl)amino]diazen-1-ium-1,2-diolate (PAPA-NONOate) were purchased from Axxora (San Diego, CA). Hydrogen peroxide was purchased from Sigma. Antibodies for phosphorylated target proteins [Thr172-AMPK, Ser79-acetyl-CoA carboxylase (ACC), Ser473-Akt, Thr980-PERK, Ser51-eukaryotic initiation factor-2α (eIF-2α)] and the following targets AMPK, PARP, and p53 were purchased from Cell Signaling Technology (Danvers, MA). Anti-PAR was purchased from Trevigen (Gaithersburg, MD). Anti-GAPDH was purchased from Ambion (Austin, TX). Horseradish peroxidase-conjugated donkey anti-rabbit and donkey anti-mouse antibodies were purchased from Jackson Immunoresearch Laboratories (West Grove, PA). PGC-1α, CCAAT/enhancer-binding protein homologous protein (CHOP), GADD45α, HSP70, p53-upregulated modulator of apoptosis (PUMA), and GAPDH primers were obtained from IDT DNA Technologies (Coralville, IA).

Islet isolation and cell culture.

Islets were isolated from male Sprague-Dawley rats (250–300 g) by collagenase digestion, as described previously (34). Islets were cultured overnight in complete CMRL-1066 (containing 2 mM l-glutamine, 10% heat-inactivated fetal calf serum, 100 U/ml penicillin, and 100 μg/ml streptomycin) at 37°C under an atmosphere of 95% air and 5% CO2 before experimentation. INS832/13 cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM glutamine, 1 mM sodium pyruvate, 55 μM β-mercaptoethanol, 10 mM HEPES, 100 U/ml penicillin, and 100 μg/ml streptomycin. Cells were maintained at 37°C under an atmosphere of 95% air and 5% CO2.

Immunoblotting.

Cells were washed twice with PBS and lysed with IP lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 0.5% NP-40, 1 mM phenylmethanesulfonyl fluoride, 25 μg/ml leupeptin, 25 μg/ml aprotinin, and 1× phosphatase inhibitor cocktail; Pierce, Rockford, IL), as described previously (47). Protein concentrations were determined using the BCA assay (Pierce, Rockford, IL). Equal amounts of protein from each sample were solubilized in Laemmli sample buffer (2% SDS) and heated for 5 min at 95°C. Proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose, and the membranes were blocked in 1% BSA and 5% dry milk, followed by an overnight incubation at 4°C with primary antibodies. Horseradish peroxidase-conjugated donkey anti-rabbit or donkey anti-mouse (1:4,000 dilution) secondary antibodies were incubated for 1 h at room temperature, followed by detection with enhanced chemiluminescence.

Subcellular fractionation.

Nuclear and cytosolic fractions were prepared as described previously (3, 46), with minor modifications. Cells were washed twice with PBS and then harvested in 200 μl of lysis buffer (10 mM Tris, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.05% Nonidet P-40, 1 mM EGTA, 1 mM sodium orthovanadate, 100 μM phenylmethanesulfonyl fluoride, 0.1 μM okadaic acid, 50 mM sodium fluoride, and 10 μg/ml each of leupeptin, aprotinin, and pepstatin). Following lysis, the cells were centrifuged at 2,700 g for 10 min at 4°C. The supernatant was collected and centrifuged at 20,800 g for 15 min at 4°C to obtain the cytosolic fraction. The pellet containing nuclei was washed twice in 200 μl of wash buffer (5 mM HEPES, pH 7.4, 3 mM MgCl2, 1 mM EGTA, 250 mM sucrose, and 0.1% BSA with protease and phosphatase inhibitors). The pellet was collected, and the nuclei were centrifuged through a 1 M sucrose cushion (with protease and phosphatase inhibitors) at 2,700 g for 10 min at 4°C, washed in lysis buffer containing 0.05% Nonidet P-40, and suspended in nuclear extraction buffer (20 mM HEPES, pH 7.9, 300 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1 mM β-glycerophosphate, 1 mM sodium orthovanadate, 100 μM phenylmethanesulfonyl fluoride, 0.1 μM okadaic acid, 50 mM sodium fluoride, and 10 μg/ml each of leupeptin, aprotinin, and pepstatin). Following a 30-min incubation on ice, nuclei were extracted by centrifugation at 20,800 g for 15 min at 4°C, with the supernatant retained as the nuclear extract.

TUNEL assay and immunocytochemistry.

DNA strand breaks were identified using the terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. Following treatment, cells were collected in PBS and centrifuged onto slides. The cells were fixed in 4% paraformaldehyde for 30 min, washed in PBS, and permeabilized with 0.1% Triton X-100 in 0.1% citrate for 3 min. The samples were labeled according to the manufacturer's instructions (Roche, Manheim, Germany). Cellular localization of GAPDH was performed by immunocytochemistry, as described previously (30, 31), using a 1:200 dilution of anti-GAPDH. Images were obtained using a Nikon 90i confocal microscope and are at ×20.

Real-time PCR.

RNA was isolated using the RNeasy kit (Qiagen), and cDNA synthesis was performed using oligo(dT) and the reverse transcriptase Superscript Preamplification System (Invitrogen) according to the manufacturer's instructions. Real-time PCR was performed using the Light Cycler 480 (Roche Applied Science) with SYBR Green incorporation for product detection. Values were normalized to β-actin and fold change calculated by the ΔΔCT method. Primer sequences were as follows: GADD45 forward (TGGCTGCGGATGAAGATGAC), GADD45 reverse (GTGGGGAGTGACTGCTTGAGTAAC); HSP70 forward (CATGAAGCACTGGCCCTTCC), HSP70 reverse (CGAAGATGAGCACGTTGCGC); PUMA forward (GCACTGATGGAGATACGGACTTG), PUMA reverse (ATGAAGGTGAGGCAGGCATTGC); β-actin forward (AGCCATGTACGTAGCCATCCAGGCTG), β-actin reverse (TGGGTACATGGTGGTACCACCAGACA); CHOP forward (AAATAACAGCCGGAACCTGA), CHOP reverse (GGGATGCAGGGTCAAGAGTA).

RESULTS

ROS and RNS induce DNA damage and the activation of stress responses in β-cells. Treatment of INS832/13 cells with the nitric oxide donor DEANO (1 mM) or H2O2 (100 μM) for 30 min results in extensive DNA strand breaks in >95% of the cells, as assessed using TUNEL staining (Fig. 1A). Similar findings were obtained using the Comet assay of DNA damage (data not shown). In response to the nitric oxide donor or H2O2, the cells did not display apoptotic morphology, as the entire nucleus contains damaged DNA (light blue nuclear staining on the merged images). We have shown previously that forced induction of apoptosis in insulinoma cells using camptothecin results in chromatin condensation with punctate TUNEL-positive staining (8).

Fig. 1.

Fig. 1.

Nitric oxide and hydrogen peroxide (H2O2) damage DNA but activate different signaling pathways. A: INS832/13 cells were treated with 1 mM (Z)-1(N,N-diethylamino) diazen-1-ium-1,2-diolate (DEANO) or 100 μM H2O2 for 30 min. DNA integrity was evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). B: INS832/13 cells were treated with 1 mM DEANO or 100 μM H2O2, followed by Western blot analysis using antibodies specific for the indicated proteins. Results are representative of 3 independent experiments, and the fold changes in activation or expression (normalized to GAPDH levels) are listed under each lane for each target. AMPK, AMP-activated protein kinase; ACC, acetyl-CoA carboxylase; PERK, eukaryotic translation initiation factor 2α kinase 3; eIF-2α, eukaryotic initiation factor-2α; PAR, poly(ADP-ribose).

To determine the cellular responses to RNS and ROS, INS832/13 cells were treated with DEANO (1 mM) or H2O2 (100 μM) for 30–90 min; the cells were harvested, and cell signaling was examined by immunoblotting. Both DEANO and H2O2 stimulate AMPK phosphorylation and phosphorylation of the AMPK substrate ACC (Fig. 1B). Whereas both ROS and RNS activate AMPK, the induction of ER stress, as evidenced by PERK and eIF-2α phosphorylation, is stimulated in response only to the nitric oxide donor. H2O2 fails to stimulate PERK or eIF-2α phosphorylation. Much like ER stress (61), DEANO stimulates JNK phosphorylation, whereas H2O2 does not activate this MAPK (Fig. 1B). We have shown previously that, in response to nitric oxide (produced endogenously by β-cells or supplied exogenously), there is a reduction in Akt-dependent phosphorylation of FoxO1, resulting in the nuclear localization of this transcription factor (32). Consistent with these previous findings, treatment with DEANO results in a decrease, whereas H2O2 does not modify Akt-dependent FoxO1 phosphorylation. In response to DNA damage, p53 is activated via protein stabilization and posttranslational modifications such as phosphorylation (39). DEANO treatment does not modify the steady-state levels of p53, whereas H2O2 treatment stimulates the time-related accumulation of p53 (Fig. 1B). PARP is also activated in response to DNA damage and translocates to sites of damaged DNA, where it undergoes auto ADP-riboyslation (PAR formation) during DNA repair (19). In response to H2O2, there is a rapid and transient increase in PAR immunoreactivity that is apparent after 30 min and lost at later time points (60 and 90 min). This transient response likely reflects the rapid consumption of the substrate NAD+ and ATP during the cycles of PARP-mediated ribosylation and hydrolysis of this modification (19). In contrast to the actions of H2O2, nitric oxide fails to stimulate the accumulation of PAR in INS832/13 cells. These findings are consistent with previous studies by our laboratory showing that PARP deficiency does not protect β-cells from cytokine-induced damage (2). These studies show that both ROS and RNS cause DNA damage and the activation of AMPK; however, additional pathways are activated in a stress-selective fashion. Nitric oxide stimulates a stress response that is characterized by the induction of the unfolded protein response (PERK/eIF-2α) and activation of the transcription factor FoxO1, whereas H2O2 induces a DNA damage repair type response characterized by p53 stabilization and PAR accumulation.

PARP participates in the activation of AMPK in response to H2O2. Because both ROS and RNS cause DNA damage (Fig. 1A), the potential exists for a common signaling pathway to converge on the AMPK signaling node. PARP appears to be a potential player in this pathway, as extensive DNA damage can lead to the overactivation of PARP, resulting in depletion of NAD+ and ATP to levels sufficient for the activation of AMPK (53, 65). To test this hypothesis, INS832/13 cells were treated with DEANO or H2O2 in the presence or absence of the PARP-selective inhibitor PJ34. The inhibition of PARP does not modify DEANO-induced AMPK phosphorylation (Fig. 2A) but attenuates H2O2-induced AMPK phosphorylation (Fig. 2B). These results were confirmed using a second nitric oxide donor, PAPANO, which stimulates the phosphorylation of AMPK and the AMPK substrate ACC in a PARP-independent fashion, whereas PJ34 attenuates H2O2-stimulated AMPK and ACC phosphorylation (Fig. 2C). In addition to the activation of AMPK, nitric oxide also attenuates the basal levels of Akt phosphorylation (32, 64), and this effect is not modified by the presence of PJ34 (Fig. 2C), whereas H2O2 treatment does not modify basal Akt phosphorylation in the presence or absence of PJ34. These findings are consistent with previous reports showing that H2O2 treatment stimulates the overactivation of PARP due to extensive DNA damage (41) and the accumulation of PAR in INS832/13 cells treated with 100 μM H2O2 (Fig. 2C). A second nitric oxide donor PAPANO, like DEANO, also does not stimulate PAR accumulation in INS832/13 cells. Furthermore, DEANO treatment does not alter, whereas H2O2 decreases, the levels of NAD+ in INS832/13 cells (data not shown). Similarly to INS832/13 cells, treatment with DEANO results in PARP-independent activation of AMPK, whereas H2O2 activates AMPK in a PARP-dependent manner in rat islets (Fig. 2D). These data indicate that both RNS and ROS activate AMPK; however, the regulatory mechanisms responsible for this activation are stimulus selective.

Fig. 2.

Fig. 2.

Nitric oxide stimulates poly(ADP-ribose) polymerase (PARP)-independent signaling to AMPK. INS832/13 cells were treated with 1 mM DEANO (A) or 100 μM H2O2 (B) in the presence or absence of the PARP-1 inhibitor PJ34 (5 μM with a 30-min pretreatment), followed by immunobloting for phosphorylated AMPK. C: cells were treated with 1 mM PAPANO or 100 μM H2O2 for 30 min, followed by Western blot analysis for the indicated proteins. D: rat islets were treated with 1 mM DEANO or 100 μM H2O2 in the absence or presence of 5 μM PJ34. Phosphorylated and total AMPK were then analyzed by Western blot. Results are representative of 3 independent experiments, and the fold changes in activation or expression (normalized to total AMPK levels) are listed under each lane for each target (A, B, and D).

Differential gene expression in response to nitric oxide and H2O2 treatment.

Much like the differences in the mechanisms of activation of AMPK, gene expression is also differentially regulated in response to RNS and ROS. Exposure to increasing concentrations of DEANO results in the accumulation of mRNA for the ER stress-responsive transcription factor CHOP (GADD153; Fig. 3), and this effect is consistent with PERK and eIF-2α phosphorylation (Fig. 1B). DEANO treatment also activates a heat shock response, as evidenced by the accumulation of HSP70 mRNA. In addition to the induction of stress response genes, nitric oxide stimulates the expression of protective genes such as GADD45α [DNA repair (49)] and PGC-1α [mitochondrial metabolism (40)]. H2O2 treatment does not modify the steady-state levels of any of these stress-responsive or protective genes (<2-fold increase in mRNA accumulation for all targets under all conditions); however, H2O2 and DEANO stimulate the accumulation of the bcl2 scavenger (PUMA) mRNA (Fig. 3). We hypothesized that PUMA expression is regulated through distinct mechanisms. PUMA is induced typically in a p53-dependent manner (48), and, consistent with this hypothesis, H2O2 stimulates p53 stabilization in INS832/13 cells (Fig. 1B). In response to nitric oxide, PUMA expression is regulated in a p53-independent, FoxO1-dependent manner (30). Consistent with this mechanism of action, nitric oxide treatment results in the attenuation of Akt-dependent phosphorylation of FoxO1 (Fig. 1B) but does not enhance p53 phosphorylation or accumulation in INS832/13 cells or rat islets (Fig. 1 and Ref. 30). These data demonstrate that ROS and RNS elicit divergent transcriptional programs.

Fig. 3.

Fig. 3.

Nitric oxide and H2O2-induced differential stress-responsive gene expression. INS832/13 cells were treated with 0.1–1 mM DEANO or 30–300 μM H2O2 for 3 h, total RNA was isolated, and the accumulation of CCAAT/enhancer-binding protein homologous protein (CHOP), GADD45, heat shock protein 70 (HSP70), PGC-1α, and p53-upregulated modulator of apoptosis (PUMA) mRNA was determined by quantitative RT-PCR. Results are means ± SE of 3 independent experiments. *P < 0.05, statistically significant changes.

Role of PARP in β-cell death triggered by exposure to ROS and RNS.

The loss of cell viability is a common feature associated with the exposure of cells to RNS and ROS (57), and the mechanisms responsible for cell death differ depending on the reactive species. In response to ROS, there is an overactivation of PARP, as evidenced by PAR formation (Figs. 1 and 2) and PARP-dependent AMPK activation (Fig. 2). Overactivation of PARP contributes to cell death in response to H2O2, as the PARP inhibitor PJ34 attenuates the loss of INS832/13 cell viability following a 4-h treatment with 100 and 300 μM H2O2 (Fig. 4A). In contrast, increasing concentrations of nitric oxide, supplied exogenously using DEANO, reduce cell viability (∼20% at 0.3 and 1 mM), and this action is PARP independent because PJ34 does not modify the loss in cell viability (Fig. 4B). These findings indicate that ROS treatment and the resulting DNA damage activate a number of pathways, leading to PARP-dependent AMPK activation and PARP-dependent cell death.

Fig. 4.

Fig. 4.

Nitric oxide stimulates PARP-independent cell death. INS832/13 cells were treated with 0.03–1 mM DEANO or 10–300 μM H2O2 in the presence or absence of PJ34 (5 μM with a 30-min pretreatment) for 4 h. Cell viability was then evaluated using the MTT assay. Results are means ± SE of 3 independent experiments. *P < 0.05, statistically significant changes.

The role of PARP overactivation in β-cell death appears to be selective for ROS. In response to RNS, PARP is not overactivated (PAR does not accumulate; Figs. 1 and 2), and PARP inhibition does not alter the loss of cell viability in response to RNS (Fig. 4). While exploring pathways by which RNS mediates β-cell damage, we observed that nitric oxide stimulates the nuclear accumulation of GAPDH (Fig. 5). Consistent with previous reports that nitric oxide stimulates cell death by a pathway that is associated with S-nitrosation and nuclear localization of GAPDH (5, 26, 60), DEANO induces the nuclear accumulation of GAPDH under conditions in which PARP is not overactivated (as evidenced by the absence of nuclear PAR formation; Fig. 5A). In contrast, H2O2 does not stimulate the nuclear accumulation of GAPDH; however, it is effective at stimulating the accumulation of PAR in the nucleus of INS832/13 cells (Fig. 5A). IL-1β is an effective stimulator of iNOS expression and the production of micromolar levels of nitric oxide by β-cells following 18- to 24-h incubations (15, 16, 18). Similar to the effects of nitric oxide donors, IL-1β stimulates the nuclear localization of GAPDH following a 20-h incubation, and nuclear GAPDH persists to 48 h (Fig. 5B). The stimulation of GAPDH nuclear localization appears to be reversible, as a 1-h incubation with DEANO stimulates nuclear localization of GAPDH, and washing to remove the nitric oxide donor, followed by continued culture for 5 h, results in a loss of GAPDH in nuclear extracts (Fig. 5C). Immunohistochemical analysis was used to confirm these biochemical findings, as PAPANO stimulates the nuclear localization of a faction of the cellular GAPDH in ∼50% of INS832/13 cells following 30-min exposure. In response to a similar exposure to H2O2, GAPDH does not translocate to the nucleus (Fig. 5, D and E). These data indicate that nitric oxide and IL-1β stimulate nuclear GAPDH accumulation and may point toward a role for nuclear GAPDH as a mediator of β-cell destruction in response to proinflammatory cytokines.

Fig. 5.

Fig. 5.

Nitric oxide and IL-1β stimulate the nuclear localization of GAPDH. A: INS832/13 cells were treated with DEANO (1 mM) or H2O2 (100 μM) for the indicated times, and nuclear extracts were prepared and analyzed by Western blot for GAPDH, PAR, and PARP. Staurosporin (STS) is shown as a positive control for apoptosis. B: INS832/13 cells were treated with DEANO (1 mM) for 1 h, washed, and incubated for an additional 5 h in the absence of the nitric oxide donor. The levels of nuclear GAPDH were determined by Western blot. C: INS832/13 cells were treated with IL-1β (10 U/ml) for the indicated times or with DEANO (0.5 mM) for 1 h. The levels of nuclear GAPDH were determined by Western blot. D: INS832/13 cells were treated with PAPANO (1 mM) or H2O2 (100 μM) for 30 or 90 min, and the levels of nuclear GAPDH were quantified by immunocytochemistry (green, GAPDH; DAPI-blue, nuclei). E: representative images of the 30-min treatment quantified in D. Results are representative (AC and E) or means ± SE (D) of 3 independent experiments. WCL, whole cell lysate (or input control).

DISCUSSION

In this study, we have examined the differential signaling stimulated by RNS and ROS. Consistent with differential signaling, RNS and ROS have divergent effects on β-cell function. Whereas RNS inhibits oxidative metabolism and subsequent glucose-stimulated insulin secretion (12, 16), ROS, as a second messenger in response to glucose, stimulates insulin secretion. However, at pathological concentrations, ROS also leads to β-cell dysfunction and cell death (52). A large body of evidence has shown that ROS and RNS modify cellular function and viability by multiple pathways, including PARP activation and energy depletion, caspase induction through mitochondrial directed pathways, prolonged ER stress, and the associated induction of apoptosis (11, 23, 41, 63). A target of both ROS and RNS is the rapid induction of DNA damage that is followed by cell death. Although the net effect of each reactive species can be the loss of viability, the process by which individual cells sense and respond to ROS and RNS is largely unknown for an individual cell type. In this report, the effects of RNS and ROS on the viability of pancreatic β-cells were explored. Cytokines, released from invading inflammatory cells during islet inflammation, are believed to contribute to the loss of pancreatic β-cell function and viability during the development of autoimmune diabetes (36). Previous studies have indicated that production of RNS and ROS is a major mediator in the process by which cytokines cause β-cell damage (37, 43), and yet the pathways that are activated and the mechanisms responsible for the loss of function and viability have not been fully elucidated. Complicating these issues is the induction of protective mechanisms, such as the heat shock and unfolded protein responses that assist in alleviating cell stress and repairing cellular damage. By directly comparing the effects of RNS and ROS on the activation of signaling cascades that control β-cell viability, we now show differential activation of signaling cascades that are consistent with protection from cellular damage (RNS) or the induction of programed necrosis and/or the more recently described PAR-mediated parthanatos (20) as a mechanism of cell death (ROS).

In response to nitric oxide, there is a rapid and pronounced activation of signaling cascades/pathways that afford protection of cells from stress or participate in β-cell recovery from cytokine-mediated damage. Nitric oxide stimulates induction of ER stress and the activation of the UPR, including enhanced phosphorylation of PERK and its substrate eIF2α and the accumulation of CHOP mRNA. The induction of ER stress in response to RNS has been described in a number of cell types (9, 24, 33, 63), including β-cells (50), and occurs in response to exogenously supplied and endogenously produced nitric oxide (7, 45). Although prolonged activation of the UPR can be associated with the induction of apoptosis (56), previous studies using insulinoma cells and isolated islets have disassociated UPR activation from the loss of β-cell viability in response to the production of nitric oxide following cytokine treatment (1, 7). Even though signaling pathways that are associated with protection from oxidant damage are activated by nitric oxide, prolonged exposure to this RNS does result in cell death in a PARP-independent manner. In contrast to RNS, H2O2 does not activate the UPR or stimulate the heat shock response.

Although there appear to be a number of differences in the response of β-cells to RNS compared with ROS, the AMPK cascade is one pathway that is modified in a similar fashion. In a time-dependent manner, both nitric oxide and H2O2 activate AMPK; however, the mechanisms of activation differ. In response to H2O2, AMPK activation correlates with the formation of PAR and is sensitive to inhibitors of PARP. In this mechanism of AMPK activation, double-stranded DNA breaks stimulate the overactivation of PARP, the rapid poly(ADP)-ribosylation of target proteins that include PARP itself (note the formation of PAR in H2O2-treated INS832/13 cells). The ATP-dependent resynthesis of NAD+ and the rapid ATP-dependent hydrolysis of the PAR modification result in a cycle of PARP-mediated NAD+ and ATP consumption, leading to the depletion of cellular ATP (25, 41). Nitric oxide also stimulates AMPK activation, but it does this in a PARP-independent fashion. Recently, we identified a requirement for the RNase activity of IRE1 in the activation of AMPK by nitric oxide (45). Furthermore, inhibitors of PARP attenuate H2O2-induced cell death, whereas they have no effect on the loss of INS832/13 cell viability in response to nitric oxide. In contrast, nitric oxide-induced INS832/13 cell death is associated with the translocation of GAPDH to the nucleus. Much like β-cells, nitric oxide stimulates the nuclear localization of GAPDH in neurons (26), and nuclear GAPDH appears to activate the histone acetyltransferase p300/CBP to stimulate cell death (60). This pathway may also participate in the control of β-cell fate in response to nitric oxide, as we have identified an acetylation-dependent role for FoxO1-dependent transcription in determining the response of β-cells to cytokine treatment (32). When the NAD+-dependent deacetylase Sirt1 is more active, nuclear FoxO1 is deacetylated and directs a protective transcriptional program that results in functional recovery and repair of damaged DNA (4, 32). This pathway includes the expression of genes such as GADD45α and PGC-1α that participate in the repair of DNA and mitochondrial damage. When less active, FoxO1 is acetylated, likely by p300, and directs a transcriptional program that results in apoptosis via the expression of PUMA (32, 51). Although both nitric oxide and H2O2 stimulate PUMA expression (Fig. 4), in response to ROS the accumulation of PUMA mRNA is likely mediated by p53, as H2O2 activates p53, as evidenced by its stabilization. Nitric oxide also stimulates PUMA mRNA accumulation; however, it fails to stabilize p53 or stimulate p53 phosphorylation (30). In contrast, nitric oxide-induced PUMA mRNA accumulation is dependent on FoxO1 (32).

In comparing our findings with previously reported actions of ROS and RNS, it appears that the responses to different forms of cellular stress are distinct and selective for individual cell types. In β-cells, the actions of RNS appear to be protective early; however, if cell damage becomes too extensive and the cells can no longer repair damaged DNA or recover oxidative metabolic capabilities, an apoptotic cascade appears to be triggered, as evidenced by the expression of PUMA (31, 32). In contrast, oxidative stress appears to stimulate programmed necrosis/parthanatos that is associated with PARP overactivation, reduced ATP levels (as evidenced by PARP-dependent AMPK activation), stabilization of p53, and PARP-dependent loss of viability. Much like the response of β-cells to exogenously supplied nitric oxide, cytokine treatment stimulates the nitric oxide-dependent activation of AMPK, accumulation of PGC-1α and GADD45α mRNA, and induction of the UPR (1, 7, 30, 44, 45). These findings suggest that, in response to cytokines, the induction of RNS directs the response of β-cells, controlling both the protective (GADD45α and PGC-1α expression) and detrimental actions of cytokines (inhibition of mitochondrial oxidation, PUMA expression) on β-cell function.

GRANTS

These studies were supported by National Institutes of Health Grants F32-DK-084645 (to G. P. Meares), DK-052194 and AI-44458 (to J. A. Corbett), and CA-131653 (to J. R. Lancaster).

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the authors.

AUTHOR CONTRIBUTIONS

G.P.M., D.F., T.A., J.R.L., and J.A.C. contributed to the conception and design of the research; G.P.M., D.F., K.A.B., and J.A.C. performed the experiments; G.P.M., D.F., K.A.B., J.R.L., and J.A.C. analyzed the data; G.P.M., D.F., K.A.B., T.A., J.R.L., and J.A.C. interpreted the results of the experiments; G.P.M., D.F., and J.A.C. prepared the figures; G.P.M., D.F., K.A.B., T.A., J.R.L., and J.A.C. drafted the manuscript; G.P.M., D.F., K.A.B., T.A., J.R.L., and J.A.C. edited and revised the manuscript; G.P.M., D.F., K.A.B., T.A., J.R.L., and J.A.C. approved the final version of the manuscript.

ACKNOWLEDGMENTS

We thank Tonya Tse for technical assistance and Drs. Hubert Tse and Albert Girotti for helpful discussions.

Present address of G. P. Meares: Department of Cell, Developmental, and Integrative Biology, The University of Alabama at Birmingham, 1918 University Blvd, MCLM 386, Birmingham, AL 35294.

REFERENCES

  • 1.Akerfeldt MC, Howes J, Chan JY, Stevens VA, Boubenna N, McGuire HM, King C, Biden TJ, Laybutt DR. Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes 57: 3034–3044, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Andreone T, Meares GP, Hughes KJ, Hansen PA, Corbett JA. Cytokine-mediated β-cell damage in PARP-1-deficient islets. Am J Physiol Endocrinol Metab 303: E172–E179, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bijur G, Jope R. Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem 276: 37436–37442, 2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011–2015, 2004 [DOI] [PubMed] [Google Scholar]
  • 5.Cahuana GM, Tejedo JR, Jiménez J, Ramírez R, Sobrino F, Bedoya FJ. Nitric oxide-induced carbonylation of Bcl-2, GAPDH and ANT precedes apoptotic events in insulin-secreting RINm5F cells. Exp Cell Res 293: 22–30, 2004 [DOI] [PubMed] [Google Scholar]
  • 6.Calabrese V, Cornelius C, Rizzarelli E, Owen J, Dinkova-Kostova A, Butterfield D. Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal 11: 2717–2739, 2009 [DOI] [PubMed] [Google Scholar]
  • 7.Chambers K, Unverferth J, Weber S, Wek R, Urano F, Corbett J. The role of nitric oxide and the unfolded protein response in cytokine-induced beta-cell death. Diabetes 57: 124–132, 2008 [DOI] [PubMed] [Google Scholar]
  • 8.Chambers K, Weber S, Corbett J. PGJ2-stimulated β-cell apoptosis is associated with prolonged UPR activation. Am J Physiol Endocrinol Metab 292: E1052–E1061, 2007 [DOI] [PubMed] [Google Scholar]
  • 9.Chen J, Qin J, Liu X, Han Y, Yang Z, Chang X, Ji X. Nitric oxide-mediated neuronal apoptosis in rats with recurrent febrile seizures through endoplasmic reticulum stress pathway. Neurosci Lett 443: 134–139, 2008 [DOI] [PubMed] [Google Scholar]
  • 10.Chipuk JE, Green DR. Dissecting p53-dependent apoptosis. Cell Death Differ 13: 994–1002, 2006 [DOI] [PubMed] [Google Scholar]
  • 11.Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48: 749–762, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 345: 50–54, 1994 [DOI] [PubMed] [Google Scholar]
  • 13.Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel ML. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes 36: 963–970, 1987 [DOI] [PubMed] [Google Scholar]
  • 14.Corbett J, McDaniel M. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 181: 559–568, 1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Corbett J, McDaniel M. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J 299: 719–724, 1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Corbett J, Sweetland M, Wang J, Lancaster JJ, McDaniel M. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90: 1731–1735, 1993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Corbett J, Wang J, Misko T, Zhao W, Hickey W, McDaniel M. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity 15: 145–153, 1993 [DOI] [PubMed] [Google Scholar]
  • 18.Corbett J, Wang J, Sweetland M, Lancaster JJ, McDaniel M. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest 90: 2384–2391, 1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.D'Amours D, Desnoyers S, D'Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342: 249–268, 1999 [PMC free article] [PubMed] [Google Scholar]
  • 20.David KK, Andrabi SA, Dawson TM, Dawson VL. Parthanatos, a messenger of death. Front Biosci 14: 1116–1128, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Di Matteo MA, Loweth AC, Thomas S, Mabley JG, Morgan NG, Thorpe JR, Green IC. Superoxide, nitric oxide, peroxynitrite and cytokine combinations all cause functional impairment and morphological changes in rat islets of Langerhans and insulin secreting cell lines, but dictate cell death by different mechanisms. Apoptosis 2: 164–177, 1997 [DOI] [PubMed] [Google Scholar]
  • 22.Goldstein BJ, Mahadev K, Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54: 311–321, 2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gotoh T, Mori M. Nitric oxide and endoplasmic reticulum stress. Arterioscler Thromb Vasc Biol 26: 1439–1446, 2006 [DOI] [PubMed] [Google Scholar]
  • 24.Gotoh T, Oyadomari S, Mori K, Mori M. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J Biol Chem 277: 12343–12350, 2002 [DOI] [PubMed] [Google Scholar]
  • 25.Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96: 13978–13982, 1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, Sawa A. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7: 665–674, 2005 [DOI] [PubMed] [Google Scholar]
  • 27.Hardie D. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32, Suppl 4: S7–S12, 2008 [DOI] [PubMed] [Google Scholar]
  • 28.Hohmeier HE, Tran VV, Chen G, Gasa R, Newgard CB. Inflammatory mechanisms in diabetes: lessons from the beta-cell. Int J Obes Relat Metab Disord 27, Suppl 3: S12–S16, 2003 [DOI] [PubMed] [Google Scholar]
  • 29.Huang Q, Shen HM. To die or to live: the dual role of poly(ADP-ribose) polymerase-1 in autophagy and necrosis under oxidative stress and DNA damage. Autophagy 5: 273–276, 2009 [DOI] [PubMed] [Google Scholar]
  • 30.Hughes K, Meares G, Chambers K, Corbett J. Repair of nitric oxide-damaged DNA in beta-cells requires JNK-dependent GADD45alpha expression. J Biol Chem 284: 27402–27408, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hughes KJ, Chambers KT, Meares GP, Corbett JA. Nitric oxides mediates a shift from early necrosis to late apoptosis in cytokine-treated β-cells that is associated with irreversible DNA damage. Am J Physiol Endocrinol Metab 297: E1187–E1196, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hughes KJ, Meares GP, Hansen PA, Corbett JA. FoxO1 and SIRT1 regulate beta-cell responses to nitric oxide. J Biol Chem 286: 8338–8348, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kawahara K, Oyadomari S, Gotoh T, Kohsaka S, Nakayama H, Mori M. Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells. FEBS Lett 506: 135–139, 2001 [DOI] [PubMed] [Google Scholar]
  • 34.Kelly C, Blair L, Corbett J, Scarim A. Isolation of islets of Langerhans from rodent pancreas. Methods Mol Med 83: 3–14, 2003 [DOI] [PubMed] [Google Scholar]
  • 35.Lacy PE, Finke EH. Activation of intraislet lymphoid cells causes destruction of islet cells. Am J Pathol 138: 1183–1190, 1991 [PMC free article] [PubMed] [Google Scholar]
  • 36.Lennon GP, Bettini M, Burton AR, Vincent E, Arnold PY, Santamaria P, Vignali DA. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 31: 643–653, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans 36: 343–347, 2008 [DOI] [PubMed] [Google Scholar]
  • 38.Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20: 463–466, 1996 [DOI] [PubMed] [Google Scholar]
  • 39.Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027–1036, 2006 [DOI] [PubMed] [Google Scholar]
  • 40.Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1: 361–370, 2005 [DOI] [PubMed] [Google Scholar]
  • 41.Luo X, Kraus WL. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev 26: 417–432, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Mathis D, Vence L, Benoist C. beta-Cell death during progression to diabetes. Nature 414: 792–798, 2001 [DOI] [PubMed] [Google Scholar]
  • 43.McDaniel M, Kwon G, Hill J, Marshall C, Corbett J. Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med 211: 24–32, 1996 [DOI] [PubMed] [Google Scholar]
  • 44.Meares GP, Hughes KJ, Jaimes KF, Salvatori AS, Rhodes CJ, Corbett JA. AMP-activated protein kinase attenuates nitric oxide-induced beta-cell death. J Biol Chem 285: 3191–3200, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Meares GP, Hughes KJ, Naatz A, Papa FR, Urano F, Hansen PA, Benveniste EN, Corbett JA. IRE1-dependent activation of AMPK in response to nitric oxide. Mol Cell Biol 31: 4286–4297, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Meares GP, Jope RS. Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis. J Biol Chem 282: 16989–17001, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Meares GP, Zmijewska AA, Jope RS. Heat shock protein-90 dampens and directs signaling stimulated by insulin-like growth factor-1 and insulin. FEBS Lett 574: 181–186, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683–694, 2001 [DOI] [PubMed] [Google Scholar]
  • 49.Niehrs C, Schafer A. Active DNA demethylation by Gadd45 and DNA repair. Trends Cell Biol 22: 220–227, 2012 [DOI] [PubMed] [Google Scholar]
  • 50.Oyadomari S, Takeda K, Takiguchi M, Gotoh T, Matsumoto M, Wada I, Akira S, Araki E, Mori M. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci USA 98: 10845–10850, 2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Perrot V, Rechler MM. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription. Mol Endocrinol 19: 2283–2298, 2005 [DOI] [PubMed] [Google Scholar]
  • 52.Pi J, Collins S. Reactive oxygen species and uncoupling protein 2 in pancreatic beta-cell function. Diabetes Obes Metab 12, Suppl 2: 141–148, 2010 [DOI] [PubMed] [Google Scholar]
  • 53.Rodríguez-Vargas JM, Ruiz-Magaña MJ, Ruiz-Ruiz C, Majuelos-Melguizo J, Peralta-Leal A, Rodríguez MI, Muñoz-Gámez JA, de Almodóvar MR, Siles E, Rivas AL, Jäättela M, Oliver FJ. ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy. Cell Res 22: 1181–1198, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519–529, 2007 [DOI] [PubMed] [Google Scholar]
  • 55.Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10: 293–301, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, Mori K, Sadighi Akha AA, Raden D, Kaufman RJ. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 4: e374, 2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9: 49–89, 2007 [DOI] [PubMed] [Google Scholar]
  • 58.Scarim A, Heitmeier M, Corbett J. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta. Endocrinology 138: 5301–5307, 1997 [DOI] [PubMed] [Google Scholar]
  • 59.Scarim A, Nishimoto S, Weber S, Corbett J. Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage. Endocrinology 144: 3415–3422, 2003 [DOI] [PubMed] [Google Scholar]
  • 60.Sen N, Hara MR, Kornberg MD, Cascio MB, Bae BI, Shahani N, Thomas B, Dawson TM, Dawson VL, Snyder SH, Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat Cell Biol 10: 866–873, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding H, Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664–666, 2000 [DOI] [PubMed] [Google Scholar]
  • 62.Valko M, Leibfritz D, Moncol J, Cronin M, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44–84, 2007 [DOI] [PubMed] [Google Scholar]
  • 63.Xu W, Liu L, Charles I, Moncada S. Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum stress response. Nat Cell Biol 6: 1129–1134, 2004 [DOI] [PubMed] [Google Scholar]
  • 64.Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, Kaneki M. S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280: 7511–7518, 2005 [DOI] [PubMed] [Google Scholar]
  • 65.Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18: 1272–1282, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Physiology - Endocrinology and Metabolism are provided here courtesy of American Physiological Society

RESOURCES